Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
40
ORKA Quote, Financials, Valuation and Earnings
Last price:
$32.04
Seasonality move
:
-5.93%
Day range:
$31.56 - $32.43
52-week range:
$5.49 - $32.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.21x
Volume:
262K
Avg. volume:
578.2K
1-year change:
52.01%
Market cap:
$1.6B
Revenue:
--
EPS (TTM):
-$2.42
Earnings Data
Next earnings date for ORKA
Mar 05
2026
Most recent earnings per share
-$0.69
Missed by $0.16
(Nov 12/2025)
Consensus Estimate
-$0.52
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ORKA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 | -- | -- | -- | -$0.63 | -- |
| 11/12/2025 | Q3 | -- | -- | -$0.69 | -$0.52 | -$0.16 |
| 08/11/2025 | Q2 | -- | -- | -$0.58 | -$0.43 | -$0.15 |
| 05/14/2025 | Q1 | -- | -- | -$0.50 | -$0.48 | -$0.03 |
| 03/06/2025 | Q4 | -- | -- | -$0.64 | -$0.98 | $0.34 |
| 11/13/2024 | Q3 | -- | -- | -$1.91 | -$0.32 | -$1.58 |
| 06/30/2024 | Q2 | -- | -- | -$6.96 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$318.67 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.90 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$1.19 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$1.23 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$1.12 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.98 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$1.94 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$2.62 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$2.72 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$4.73 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$3.92 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$4.03 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$3.98 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$6.44 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$3.95 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$8.71 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$9.94 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$9.23 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$9.12 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$13.64 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$22.29 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$23.10 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$24.71 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$32.83 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$43.37 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$76.99 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$83.24 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$127.91 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$103.03 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$100.93 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$110.16 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$92.88 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$86.40 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$75.60 | -- | -- |
Oruka Therapeutics, Inc. Earnings Questions
-
How Much did Oruka Therapeutics, Inc. Generate in Revenue Last Quarter?
Oruka Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Oruka Therapeutics, Inc. Beat Earnings Last Quarter?
Oruka Therapeutics, Inc. announced earnings per share of -$0.69 which represents a miss of analyst forecast a -$0.52 per share.
-
Is Oruka Therapeutics, Inc. Profitable?
Oruka Therapeutics, Inc. reported -$20K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Oruka Therapeutics, Inc. EPS Next Year?
Oruka Therapeutics, Inc.'s earnings are forecast to decrease from -$4.99 per share to -$2.72 per share next year representing a decrease of -58.16%.
-
When is Oruka Therapeutics, Inc.'s Earnings Date?
Oruka Therapeutics, Inc.'s next earnings date is March 5, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
